Byung-Hyun Park Selected Research

Type 1 Diabetes Mellitus (Autoimmune Diabetes)

4/2015	Polyphenols isolated from Broussonetia kazinoki prevent cytokine-induced β-cell damage and the development of type 1 diabetes.
5/2014	Transplantation of betacellulin-transduced islets improves glucose intolerance in diabetic mice.
11/2013	The efficacy of SPA0355 in protecting β cells in isolated pancreatic islets and in a murine experimental model of type 1 diabetes.
1/2011	A prenylated flavan from Broussonetia kazinoki prevents cytokine-induced β-cell death through suppression of nuclear factor-κB activity.
1/2011	Butein from Rhus verniciflua protects pancreatic β cells against cytokine-induced toxicity mediated by inhibition of nitric oxide formation.
9/2009	Dihydroavenanthramide D protects pancreatic beta-cells from cytokine and streptozotocin toxicity.
4/2009	Fructus Xanthii extract protects against cytokine-induced damage in pancreatic beta-cells through suppression of NF-kappaB activation.
2/2009	Sulforaphane protects against cytokine- and streptozotocin-induced beta-cell damage by suppressing the NF-kappaB pathway.
10/2008	Beneficial effect of Flos magnoliae extract on multiple low dose streptozotocin-induced type 1 diabetes development and cytokine-induced beta-cell damage.
9/2008	Making insulin-deficient type 1 diabetic rodents thrive without insulin.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Byung-Hyun Park Research Topics

Disease

26	Neoplasms (Cancer) 03/2024 - 03/2002
26	Inflammation (Inflammations) 01/2023 - 11/2008
15	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2015 - 05/2003
15	Insulinoma 09/2010 - 05/2003
14	Obesity 07/2020 - 12/2006
12	Necrosis 12/2022 - 08/2011
10	Rheumatoid Arthritis 07/2023 - 04/2003
10	Insulin Resistance 01/2019 - 12/2013
9	Body Weight (Weight, Body) 04/2020 - 07/2006
8	Carcinogenesis 01/2022 - 01/2009
7	Fibrosis (Cirrhosis) 06/2022 - 09/2004
7	Carcinoma (Carcinomatosis) 01/2020 - 12/2007
7	Arthritis (Polyarthritis) 12/2018 - 06/2008
6	Infections 11/2022 - 01/2002
6	Neoplasm Metastasis (Metastasis) 10/2021 - 02/2013
6	Breast Neoplasms (Breast Cancer) 01/2021 - 07/2009
6	Osteosarcoma (Osteogenic Sarcoma) 11/2020 - 09/2011
6	Hyperglycemia 01/2020 - 09/2007
6	Experimental Arthritis 03/2016 - 08/2010
5	Glucose Intolerance 04/2020 - 05/2014
5	Ischemia 01/2017 - 06/2008
4	Bone Resorption 03/2024 - 03/2011
4	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2023 - 01/2021
4	Reperfusion Injury 12/2022 - 06/2008
4	Type 2 Diabetes Mellitus (MODY) 01/2020 - 07/2014
4	Hypoxia (Hypoxemia) 09/2017 - 04/2003
4	Experimental Melanoma 10/2012 - 06/2008
3	Non-alcoholic Fatty Liver Disease 01/2023 - 01/2017
3	Liver Diseases (Liver Disease) 06/2022 - 01/2020
3	Osteoporosis 10/2020 - 01/2016
3	Hyperlipidemias (Hyperlipidemia) 06/2015 - 06/2008
3	Leukemia 07/2007 - 01/2002
2	Autoimmune Diseases (Autoimmune Disease) 07/2023 - 05/2014
2	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 12/2007
2	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2021
2	Cholestasis 06/2022 - 04/2022
2	Stomach Neoplasms (Stomach Cancer) 05/2021 - 07/2009
2	Dermatitis 01/2021 - 01/2021
2	Osteoarthritis 01/2021 - 04/2014
2	Bone Diseases (Bone Disease) 10/2020 - 09/2017

Drug/Important Bio-Agent (IBA)

27	CytokinesIBA 12/2022 - 05/2003
13	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2013
12	Sirtuin 1IBA 07/2023 - 10/2008
12	SirtuinsIBA 01/2023 - 07/2013
10	Insulin (Novolin)FDA Link 01/2021 - 09/2007
8	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2008
8	Streptozocin (Streptozotocin)FDA Link 04/2015 - 07/2006
8	Interleukin-1beta (Interleukin 1 beta)IBA 09/2010 - 05/2003
7	Interferon-gamma (Interferon, gamma)IBA 07/2010 - 05/2003
6	CateninsIBA 01/2022 - 01/2013
6	LipidsIBA 11/2016 - 09/2004
6	LeptinIBA 03/2015 - 09/2004
6	NF-kappa B (NF-kB)IBA 02/2011 - 04/2003
5	Transaminases (Aminotransferases)IBA 12/2022 - 08/2011
5	Indicators and Reagents (Reagents)IBA 10/2021 - 07/2009
5	Blood Glucose (Blood Sugar)IBA 07/2020 - 07/2015
5	AMP-Activated Protein KinasesIBA 01/2018 - 01/2015
4	EnzymesIBA 04/2020 - 06/2008
4	SPA0355IBA 01/2019 - 11/2013
4	Caspase 3 (Caspase-3)IBA 01/2019 - 01/2002
3	p21-Activated KinasesIBA 03/2024 - 01/2022
3	Histone Deacetylases (Histone Deacetylase)IBA 07/2023 - 01/2021
3	NAD (NADH)IBA 01/2023 - 01/2022
3	Therapeutic UsesIBA 06/2022 - 01/2014
3	Bile Acids and Salts (Bile Acids)IBA 06/2022 - 01/2020
3	Imiquimod (Aldara)FDA LinkGeneric 12/2021 - 01/2021
3	Protein Kinases (Protein Kinase)IBA 01/2021 - 10/2015
3	Estrogens (Estrogen)FDA Link 10/2020 - 01/2019
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2019 - 06/2008
3	Phosphotransferases (Kinase)IBA 01/2018 - 05/2013
3	Metformin (Glucophage)FDA LinkGeneric 08/2016 - 12/2013
3	OvalbuminIBA 12/2014 - 09/2010
3	Matrix Metalloproteinases (MMPs)IBA 09/2013 - 05/2011
3	Complementary DNA (cDNA)IBA 07/2013 - 09/2004
3	pregna-4,17-diene-3,16-dione (guggulsterone)IBA 10/2012 - 06/2008
3	sulforaphaneIBA 09/2011 - 06/2008
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2008 - 01/2002
3	PerforinIBA 12/2007 - 01/2002
2	salicylhydroxamic acid (SHAM)IBA 12/2022 - 10/2015
2	BilirubinIBA 06/2022 - 04/2022
2	Interleukin-23 (Interleukin 23)IBA 12/2021 - 01/2021
2	Cadherins (E-Cadherin)IBA 05/2021 - 01/2018
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021 - 01/2021
2	Small Interfering RNA (siRNA)IBA 01/2021 - 09/2013
2	Sirtuin 2IBA 01/2021 - 01/2017
2	olaparibIBA 11/2020 - 05/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020 - 05/2018
2	AntioxidantsIBA 07/2020 - 09/2009
2	CholesterolIBA 01/2020 - 06/2015
2	CollagenIBA 01/2019 - 12/2018
2	Conditioned Culture MediaIBA 01/2019 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 05/2018 - 01/2009
2	InterferonsIBA 01/2018 - 11/2007
2	VimentinIBA 01/2018 - 12/2007
2	Adenosine Monophosphate (AMP)IBA 01/2018 - 01/2018
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2018 - 07/2015

Therapy/Procedure

6	Therapeutics 01/2021 - 02/2007
3	Ligation 06/2022 - 01/2020
2	Oral Administration 06/2022 - 04/2022
2	Intradermal Injections 12/2021 - 01/2021